Marc Weder - Chief Scientific Officer
Geocann’s VESIsorb® cannabidiol formulation delivers superior pharmacokinetic performance in published study
14 avr. 2020 12h00 HE | Geocann
FORT COLLINS, Colo., April 14, 2020 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the peer-reviewed journal, Molecules, has published the results of a double-blind, cross-over study...
Hemp Products Powered By VESIsorb
Geocann is first-to-market introducing cannabigerol (CBG) formulations utilizing the VESIsorb® drug delivery system
23 août 2019 11h00 HE | Geocann
FORT COLLINS, Colo., Aug. 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first cannabigerol (CBG) soft gel products that utilize the...
Geocann Logo_Full (002).png
Geocann Appoints Medical and Scientific Advisory Board to Expand Its Leadership Position in Research and Innovation
25 juil. 2019 19h00 HE | Geocann
FORT COLLINS, Colo., July 25, 2019 (GLOBE NEWSWIRE) -- Geocann has appointed the first members of its Medical and Scientific Advisory Board. They will play an integral role in clinical study design,...
Geocann Logo_Full (002).png
Geocann Launches Patent-Protected Cannabis Formulations For Rapid Uptake Edible and Beverage Products
23 juil. 2019 17h30 HE | Geocann
FORT COLLINS, Colo., July 23, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized a portfolio of food and beverage cannabis formulations that...
Atrium Innovations Hemp Products Utilizing VESIsorb
Atrium Innovations Launches VESIsorb® Formulated Hemp Products Under Industry Leading Brands
29 mai 2019 09h20 HE | Geocann
FORT COLLINS, Colo., May 29, 2019 (GLOBE NEWSWIRE) -- Geocann and Atrium Innovations are proud to announce the successful launch of cannabidiol (CBD) soft gel formulations utilizing the patented...
Anthony Petraglia MD Geocann Headshot
Respected Neurosurgeon Brings Distinguished Career and Medical Expertise to Geocann’s Executive Management Team
14 mai 2019 10h15 HE | Geocann
FORT COLLINS, Colo., May 14, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that Anthony Petraglia, M.D., has joined the company’s executive management team as Chief Medical Officer where he...
Geocann Logo_Full (002).png
Geocann Announces Proven Stability Data Ensuring Desired Levels of Active Ingredients Are Maintained Throughout Promised Shelf-Life
09 mai 2019 15h52 HE | Geocann
FORT COLLINS, Colo., May 09, 2019 (GLOBE NEWSWIRE) -- Geocann continues to set new industry standards in cannabinoid product safety and efficacy through its two-year stability data of hemp oil...
Geocann Logo_Full (002).png
Geocann Launches Cannabidiol (CBD) Soft Gel Formulations Utilizing Patented Drug Delivery Technology
06 mai 2019 16h00 HE | Geocann
FORT COLLINS, Colo., May 06, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully commercialized the first formulation in a robust portfolio of CBD soft gel...
Longstanding Formulation Partnership
Geocann Introduces Patent-Protected VESIsorb® Formulated Cannabis Products to the Global Marketplace
19 avr. 2019 14h56 HE | Geocann
FORT COLLINS, Colo., April 19, 2019 (GLOBE NEWSWIRE) -- Geocann is proud to announce that the company has successfully leveraged a robust intellectual property portfolio by applying patented drug...